文献速递生殖医学

日本IVF/ICSI患者中促卵泡激素δ的随机剂量效应试验

Randomized, assessor-blind, antimüllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta.
PubMed 文献 · Fertil Steril · 2020-12-04

这项随机、评估者盲法、按AMH分层的剂量效应试验纳入158名20-39岁日本女性,比较促卵泡激素δ 6、9、12 μg/d与促卵泡激素β 150 IU/d在拮抗剂方案中的卵巢反应。结果显示促卵泡激素δ的获卵数随剂量增加而显著增加,且各AMH分层内均显著;活产率和早发中重度OHSS率在12 μg/d组数值较高,82%的OHSS病例来自高AMH分层。

要点

  • 促卵泡激素δ 6、9、12 μg/d组平均获卵数分别为7.0、9.1、11.6个,呈显著剂量关系。
  • 促卵泡激素δ各剂量组每启动周期活产率分别为19%、20%、25%。
  • 早发中重度OHSS率6 μg/d为8%、9 μg/d为8%、12 μg/d为13%,82%病例在高AMH分层。

核心结论

  • 本试验在日本女性中建立了促卵泡激素δ与卵巢反应之间的剂量效应关系。

研究设计与样本

  • 随机、对照、评估者盲法、按AMH分层(低5.0-14.9 pmol/L;高15.0-44.9 pmol/L)的剂量效应试验。
  • 共纳入158名20-39岁日本女性,在生殖医学诊所接受IVF/ICSI治疗。
  • 干预为促卵泡激素δ 6、9或12 μg/d,或促卵泡激素β 150 IU/d参照组,在GnRH拮抗剂周期中控制性卵巢刺激。

主要发现

  • 所有启动刺激的女性中,6、9、12 μg/d促卵泡激素δ组平均获卵数分别为7.0±4.1、9.1±5.6、11.6±5.6,呈显著剂量关系,且各AMH分层内仍显著。
  • 促卵泡激素δ在刺激末血清雌二醇、抑制素A和孕酮也观察到显著剂量反应。
  • 促卵泡激素δ每启动周期活产率6 μg/d为19%、9 μg/d为20%、12 μg/d为25%。
  • 促卵泡激素δ早发中重度OHSS率6 μg/d为8%、9 μg/d为8%、12 μg/d为13%,82%病例在高AMH分层。

关键数值与推荐

  • AMH分层标准:低5.0-14.9 pmol/L,高15.0-44.9 pmol/L。
  • 促卵泡激素δ剂量为6、9、12 μg/d;参照促卵泡激素β为150 IU/d。
  • 主要结局为获卵数。

临床怎么用

  • 日本IVF/ICSI患者使用促卵泡激素δ时,可根据AMH分层和剂量-获卵数关系选择起始剂量。
  • 高AMH分层患者使用促卵泡激素δ时OHSS风险较高,尤其12 μg/d组,需加强监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To establish the relationship between follitropin delta doses (recombinant follicle-stimulating hormone produced from the human cell line PER.C6) and ovarian response in Japanese women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment and to evaluate the influence of initial antimüllerian hormone (AMH) levels. DESIGN: Randomized, controlled, assessor-blind, AMH-stratified (low 5.0-14.9 pmol/L; high 15.0-44.9 pmol/L) dose-response trial. SETTING: Reproductive medicine clinics. PATIENT(S): A total of 158 Japanese women (20-39 years of age). INTERVENTION(S): Controlled ovarian stimulation with 6, 9, or 12 μg/d of follitropin delta or 150 IU/d follitropin beta as a reference arm in a gonadotropin-releasing hormone antagonist cycle. MAIN OUTCOME MEASURE(S): Number of oocytes retrieved. RESULT(S): Among all women who started stimulation, the mean number (± standard deviation) of oocytes retrieved in the 6 μg/d, 9 μg/d, and 12 μg/d follitropin delta groups was 7.0 ± 4.1, 9.1 ± 5.6, and 11.6 ± 5.6, respectively, and a significant dose-relation was established, which also remained significant within each AMH strata. Significant dose-responses also were observed for serum estradiol, inhibin A, and progesterone at end-of-stimulation with follitropin delta. The vital pregnancy rate per started cycle with follitropin delta was 19% for 6 μg/d, 20% for 9 μg/d, and 25% for 12 μg/d. The rate of early moderate/severe ovarian hyperstimulation syndrome with follitropin delta was 8% for 6 μg/d, 8% for 9 μg/d, and 13% for 12 μg/d, with 82% of the cases in the high AMH stratum. CONCLUSION(S): This trial establishes the dose-response relationship between follitropin delta and ovarian response in Japanese women. CLINICAL TRIAL REGISTRATION NUMBER: NCT02309671.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Ishihara O, Klein BM, Arce JC, et al. Randomized, assessor-blind, antimüllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta. Fertil Steril. 2020. PMID: 33272623. doi:10.1016/j.fertnstert.2020.10.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。